Oxford Cannabinoid Technologies Holdings (OCTP) RNS Announcements

Add to Alert list
Date Time Source Announcement
06 Jun 2024 08:00 AM
RNS
Cancellation - Oxford Cannabinoid Tech Hldgs Plc
06 Jun 2024 08:00 AM
RNS
Removal - Oxford Cannabinoid Tech Holdings Plc
06 Jun 2024 07:00 AM
RNS
Cancellation of Listing
31 May 2024 07:00 AM
RNS
Updated Shareholder Engagement
17 May 2024 04:30 PM
RNS
Updated Shareholder Information
08 May 2024 07:00 AM
RNS
Intended Cancellation of Listing
11 Apr 2024 11:26 AM
RNS
Appointment of Phase I Clinical Trial CRO
03 Apr 2024 08:00 AM
RNS
OCT Company Update with Doceo
26 Mar 2024 10:56 AM
RNS
Oxford Cannabinoid Technologies video with Doceo
18 Mar 2024 07:00 AM
RNS
Appointment of Hybridan as Adviser
29 Feb 2024 07:02 AM
RNS
Directorate Appointment
29 Feb 2024 07:02 AM
RNS
Directorate Appointment
29 Feb 2024 07:01 AM
RNS
Directorate Changes
29 Feb 2024 07:00 AM
RNS
Total Voting Rights
28 Feb 2024 05:35 PM
RNS
TR-1: NOTIFICATION OF MAJOR HOLDINGS
28 Feb 2024 05:34 PM
RNS
TR-1: NOTIFICATION OF MAJOR HOLDINGS
28 Feb 2024 05:34 PM
RNS
TR-1: NOTIFICATION OF MAJOR HOLDINGS
26 Feb 2024 01:07 PM
RNS
Directors’ Dealings
19 Feb 2024 01:52 PM
RNS
Result of General Meeting
16 Feb 2024 07:00 AM
RNS
Completion of Capital Reorganisation
15 Feb 2024 07:00 AM
RNS
Subscription
14 Feb 2024 12:53 PM
RNS
Capital Reorganisation
09 Feb 2024 07:00 AM
RNS
Edison issues update on OCTP
02 Feb 2024 03:17 PM
RNS
Notice of General Meeting & Posting of Circular
02 Feb 2024 03:13 PM
RNS
Convertible Loan Note Agreements
30 Jan 2024 07:04 AM
RNS
Fundraising and Proposed Capital Reorganisation
30 Jan 2024 07:02 AM
RNS
R&D Tax Credit
30 Jan 2024 07:00 AM
RNS
Half-year Report
23 Jan 2024 07:00 AM
RNS
Notice of Results
10 Jan 2024 07:00 AM
RNS
Patent Applications
14 Nov 2023 07:00 AM
RNS
Directorate Appointment
24 Oct 2023 07:00 AM
RNS
TR-1: Notification of major holdings
20 Oct 2023 07:01 AM
RNS
TR-1: Notification of major holdings
20 Oct 2023 07:00 AM
RNS
Director Dealing
10 Oct 2023 07:00 AM
RNS
Phase I Clinical Trial Results
29 Sep 2023 07:00 AM
RNS
Result of AGM
25 Sep 2023 07:00 AM
RNS
Final Dose Administered
05 Sep 2023 04:18 PM
RNS
Notice of AGM
31 Aug 2023 07:00 AM
RNS
2023 Final Results
22 Aug 2023 07:00 AM
RNS
Notice of Results
27 Jul 2023 07:00 AM
RNS
First Dose Administered & Pain Specialist Adviser
17 Jul 2023 01:16 PM
RNS
Director/PDMR Share Purchases
17 Jul 2023 07:00 AM
RNS
Expansion into oncology
12 Jul 2023 07:00 AM
RNS
Investor Presentation and Q&A – Programmes update
15 Jun 2023 09:50 AM
RNS
OCTP update from Doceo
08 Jun 2023 07:00 AM
RNS
Appointment of Chief Medical Officer
17 May 2023 07:00 AM
RNS
MHRA & REC 2 Approval for Phase 1 Clinical Trial
12 Apr 2023 07:00 AM
RNS
Directorate Change, Renewal of Licence & Update
14 Mar 2023 02:05 PM
RNS
Second Price Monitoring Extn
14 Mar 2023 02:00 PM
RNS
Price Monitoring Extension

Oxford Cannabinoid Technologies Holdings is a clinical stage biopharmaceutical company focused on the development and commercialisation of innovative cannabinoid medicines. In May 2024 it announced that it applied to the Financial Conduct Authority and London Stock Exchange plc to effect a cancellation of listing of its ordinary shares on the Standard segment of the FCA's Official List and trading on the Main Market for listed securities of the LSE.

Oxford Cannabinoid Technologies Holdings was listed in London under the ticker OCTP.

UK 100

Latest directors dealings